Skip to content

Clinical trials

Completed Alzheimer Disease trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Alzheimer Disease Status: Completed Country / region: Taiwan Clear all

41 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20033
20081
20094
20102
20112
20123
20131
20144
20155
20161
20172
20182
20192
20203
20212
20222
20242

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chang Gung Memorial Hospital9
National Taiwan University Hospital4
Chung Shan Medical University3
Eli Lilly and Company2
H. Lundbeck A/S2
Novartis Pharmaceuticals2
United Biomedical2
Axovant Sciences Ltd.1
Cheng Sheng Chen1
China Medical University Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Alzheimer Disease41
Cognitive Dysfunction11
Dementia6
Neurodegenerative Diseases2
Neuroinflammatory Diseases2
Plaque, Amyloid2
Stroke2
Acute Kidney Injury1
Amyloid Neuropathies, Familial1
Amyloidosis1

Trials

Showing 1 to 25 of 41. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.